This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Ryan W Chau
Introduction
Ryan W Chau is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various diseases.
Latest Patents
Ryan W Chau holds a patent for "N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof." This invention focuses on certain substituted N-(heteroaryl) quinazolin-2-amine derivatives, which are potent inhibitors of LRRK2 kinase. These compounds may be useful in the treatment or prevention of diseases such as Parkinson's Disease, where LRRK2 kinase plays a crucial role. The patent also covers pharmaceutical compositions that include these compounds and their applications in treating diseases associated with LRRK2 kinase.
Career Highlights
Ryan W Chau is currently associated with Merck Sharp & Dohme LLC, a leading pharmaceutical company. His work involves research and development aimed at creating innovative solutions for complex health issues. His expertise in medicinal chemistry and pharmacology has contributed to advancements in drug development.
Collaborations
Ryan has collaborated with talented individuals such as Santhosh F Neelamkavil and Elsie C Yu. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Ryan W Chau's contributions to the pharmaceutical industry, particularly through his patent on LRRK2 inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new treatments for diseases like Parkinson's, showcasing the importance of innovation in healthcare.